Researchers explore several factors in the health and well-being of patients with lupus
Chronotherapy with Glucorticoids in Rheumatoid Arthritis
Time is of the essence in balancing risks and benefits
Phoning It In
The missed message on methotrexate
A Review of Wegener’s Treatment Data
Clinical trials show changing role of existing treatment and introduction of newer medications
Treat JIA Without Slowing Growth
Etanercept does not impede normal height and weight development in these patients
Macrophage Activation Syndrome
A review of diagnosis, treatment, and prognosis
Can Technology Help Solve Scleroderma Renal Crisis?
A case study in using the Internet to facilitate rare disease research
New GIOP Guidelines Available
The ACR published new recommendations for the management of glucocorticoid-induced osteoporosis (GIOP) in the November issue of Arthritis Care & Research. These guidelines have been endorsed by the American Society for Bone and Mineral Research. They apply to adult patients receiving oral glucocorticoid therapy.
Naturally Occurring Antibodies May Lead to New RA Therapies
A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.
Coding Corner Question
December’s Coding Challenge
- « Previous Page
- 1
- …
- 307
- 308
- 309
- 310
- 311
- …
- 334
- Next Page »